The Freely Filtered episode on LIBERATE is live www.nephjc.com/freelyfilter... with Ian McCoy, Chi-yuan Hsu and Sam Silver providing valuable insight
FF91 Liberate-D — NephJC
Liberate D another less is more in the field of acute dialysis
nephjc.com
J Pedro Teixeira (a.k.a. Jwow)
@nephcrit.bsky.social
Husband. Father. Son. Portuguese-American. Critical care nephrologist, acute HD/CRRT director, renal fellowship APD, and clinical trialist at U New Mexico. Inflatable 🦄 owner. Tweets my own. #BlackLivesMatter. 🏳️🌈 He/him/his.
The Freely Filtered episode on LIBERATE is live www.nephjc.com/freelyfilter... with Ian McCoy, Chi-yuan Hsu and Sam Silver providing valuable insight
FF91 Liberate-D — NephJC
Liberate D another less is more in the field of acute dialysis
nephjc.com
Freely Filtered for Liberate-D just dropped! We had a great time talking with some of the study authors and learning why we should be saying “No” more frequently @hswapnil.medsky.social @captainchloride.bsky.social
FF91 Liberate-D
Podcast Episode · Freely Filtered, a NephJC Podcast · March 30 · 1h 36m
podcasts.apple.com
🧂New @freelyfiltered.bsky.social episode on hyponatremia correction #NephJC 🍾How can Brussels champagne help with hypoNa? 🎙️ Special invites: Ewot Hoorn @bettercallseeth.bsky.social 🎙️Filtrate: @kidneyboy.bsky.social @hswapnil.medsky.social @nephcrit.bsky.social www.nephjc.com/freelyfilter...
FF93 Hyponatremia Interventional Trial — NephJC
Time to fix the sodium! The Hyponatremia Intervention Trial
nephjc.com
🦵Had our Kick-off meeting today to welcome a new class of #NephJC interns (year 12 and counting). 👁️Keep an eye out for new blog and VA creators. See if you can Catch'em All🎣 #NephSky #MedSky @hswapnil.medsky.social @kidneyboy.bsky.social @nephroseeker.medsky.social @dramiliflores.bsky.social
Crazy happenings at the #ADA26 Cops show up, snatch papers and shove scientists out www.medpagetoday.com/special-repo...
Video: Police Tussle With Diabetes Experts at ADA Meeting
Researchers told they could no longer attend the annual scientific sessions
medpagetoday.com
More coverage from the @seattletimes-rss.bsky.social www.seattletimes.com/seattle-news... incl interview with UW Prof Steve Kahn
seattletimes.com
Crazy happenings at the #ADA26 Cops show up, snatch papers and shove scientists out www.medpagetoday.com/special-repo...
I will be starting TOON : Transformation Oriented Opinion (for) Nephrology a safe space for laughs, videos, deep dives, AI, blockchain and NFTs powered by Claude and facilitated by chatGPT. US professionals only for how as I want a clean IPO. Will you join me in monetizing You?
more h/t @nephcrit.bsky.social www.fda.gov/drugs/drug-a... accusations of selectively re-adjudicating with an intent to p-hack #Avacopan #Tavneos
CDER proposes to withdraw approval of TAVNEOS
CDER proposes to withdraw approval of TAVNEOS
fda.gov
B cell therapies in IgAN advance: povetacicept from Vertex www.medscape.com/s/viewarticl... #NephMadness timing was perfect for this Atacicept has competition now (and there’s the Chinese Telitacicept)
Vertex to Seek US Approval After Promising Late-stage Results for Kidney Drug
Vertex Pharmaceuticals said on Monday that its experimental drug sharply reduced a key sign of kidney damage in a late‑stage trial, putting the company on track to seek...
medscape.com
SLANH 🌎 survey (Mar–Dec 2024; n=505; 20 LA countries): EBP for AKI 👉🏻IHD 98%, PD 65%, CRRT 59% (unavailable in 🇭🇹, 🇳🇮, 🇵🇾 & 🇻🇪). Advanced EBP scarce: ECMO 16.7%, ECCO₂R 7%. Top training needs: ECMO, ECCO₂R, CRRT, TPE. @SLANH_ #AKI #EBP 🔗 doi.org/10.1159/0005...
Extracorporeal Blood Purification Therapies in Latin America – Bridging Gaps in Availability and Training
Abstract. Introduction: Socioeconomic and developmental diversity across Latin America (LA) significantly affects the availability of extracorporeal blood purification (EBP) therapies to treat acute k...
doi.org
Proud to have been part of this newly published phase 2 RCT in AKI + iron deficiency (n=120). A single 1,200 mg IV iron dextran infusion was safe but did not reduce MAKE at 90 days vs usual care (82% vs 75%; p=0.37). #AKI #Nephrology #ClinicalTrials 🔗 journals.lww.com/kidney360/ab...
https://journals.lww.com/kidney360/abstract/9900/effect_of_intravenous_iron_dextran_on_kidney.871.aspx
journals.lww.com
A multicenter retrospective HRS-HARMONY study (11 🇺🇸 🏥 systems; n=374 cirrhosis + AKI requiring dialysis): HRS-AKI was not associated with higher 90-day mortality vs other AKI etiologies. Overall mortality 59.6%—similar to other AKI-dialysis cohorts. 🔗 journals.lww.com/kidney360/fu...
https://journals.lww.com/kidney360/fulltext/2025/02000/association_of_hepatorenal_syndrome_acute_kidney.12.aspx
journals.lww.com
recording another episode of @freelyfiltered.bsky.social like @nephcrit.bsky.social at BICARICU2 I was in a minroty in this discussion thanks @ucsfnephrology.bsky.social and @nephroninja.bsky.social and Sam Silver for joining us!
Wow - excellent discussion of the totally underwhelming BICAR-ICU2 trial podcasts.apple.com/ca/podcast/f... @nephcrit.bsky.social fighting a line fight against the unimpressed nephrons with guest @weddellite.bsky.social #NephSky #EMIMCC
FF 88 BICARICU-2, Bicarbonate in the ICU. Helpful or just a number fixer?
Podcast Episode · Freely Filtered, a NephJC Podcast · 2025-12-27 · 1h 25m
podcasts.apple.com
Time to grill Charmaine Lok about fish oil for the next Freely Filtered with @nephcrit.bsky.social and @hswapnil.medsky.social
Nice of @ajkd.bsky.social to recognize this! Congrats to @karenwoomd.bsky.social @nephcrit.bsky.social @amyaimei.bsky.social and all the others! ajkdblog.org/2025/11/06/2... #NephSky #KidneyWk
2025 Inductees to the AJKD Reviewer Hall of Fame
In 2017, we began recognizing reviewers who have distinguished themselves by consistently providing insightful, detailed, and valuable input to our authors and our editorial team. We continue the t…
ajkdblog.org
ICYMI, recording now live Excellent exposition on lower doses, anti coagulation and much more. Lot of RCTs in this space youtu.be/xfEVlh_68vc?... by @nephcrit.bsky.social #NephGR #NephSky
Updates in CRRT with Dr Pedro Texeira
YouTube video by Ottawa Nephrology
youtu.be
Coming up this week! We have @nephcrit.bsky.social talking to us about CRRT #NephGR at @uottawa.ca @ottawahospital.on.ca
Coming up this week! We have @nephcrit.bsky.social talking to us about CRRT #NephGR at @uottawa.ca @ottawahospital.on.ca
The October academic activities in nephrology at @uottawa.ca @ottawahospital.on.ca Feat @nephcrit.bsky.social @dialysisbloke.bsky.social and @asakhuja.bsky.social #NephGR #NephSky
ICU Snapshots: Walking from room to room in the ICU, you see this on the monitor of a 60 yo female patient admitted the previous night with severe community-acquired pneumonia & what you were told was "refractory" septic/cardiogenic shock. Arterial line was in the R fem artery:
Is this the earliest description of contrast nephropathy from 1959? @juancarlosqvelez.bsky.social pubmed.ncbi.nlm.nih.gov/14437345/ Several aspects still key - immediate oliguria - recovery by 2 weeks - false positive urine protein - high dose contrast #NephSky
Renal insufficiency after oral administration of a double dose of a cholecystographic medium: report of two cases - PubMed
Renal insufficiency after oral administration of a double dose of a cholecystographic medium: report of two cases
pubmed.ncbi.nlm.nih.gov
Don't miss our NEW regular feature, "5 Nephrologists, 1 Question." This time, we asked about recent tools and tech that are changing nephrology practice. #nephrology #nephsky #nephrologist #kidneycare www.docwirenews.com/post/5-nephr... @jordybc.bsky.social @nephcrit.bsky.social
5 Nephrologists, 1 Question: Practice-Changing Tools and Tech | Docwire News
In this new recurring section, Nephrology Times asked five nephrologists: What technology or tool has changed your practice the most in the last 5 years?
docwirenews.com
Core Curriculum by @nephcrit.bsky.social , @hswapnil.medsky.social , Abdulghani Omar Kabli, Oleksa G. Rewa, and Edward G. Clark: Continuous Kidney Replacement Therapies: Core Curriculum 2025 bit.ly/TeixeiraCC25 (FREE)
🩺💬 Ever wonder why CRRT is the go-to in the ICU? Or how to de-escalate #CKRT safely? Kidney Commute: Pitstop dives into the latest AJKD Core Curriculum update on CKRT. 🔗 Listen now: www.kidney.org/podcasts/kid... #MedEd #Nephrology #KidneyCare @annagaddy.bsky.social @ajkd.bsky.social
In which I become an honorary Canadian citizen 🇨🇦 @nephcrit.bsky.social @hswapnil.medsky.social
🩺💬 Ever wonder why CRRT is the go-to in the ICU? Or how to de-escalate #CKRT safely? Kidney Commute: Pitstop dives into the latest AJKD Core Curriculum update on CKRT. 🔗 Listen now: www.kidney.org/podcasts/kid... #MedEd #Nephrology #KidneyCare @annagaddy.bsky.social @ajkd.bsky.social
Want to learn about CRRT in a hands-on manner in a fun and relaxed environment directly from some of the biggest experts in the world, including the Queen of CRRT herself, Dr. Tolwani??If so, you need to come to 'Bama in September! check out the video: bitly.cx/heI5 register here: rb.gy/l49le1
UAB_CRRT_2025_WKSQ_03
This is "UAB_CRRT_2025_WKSQ_03" by Cedar Creative on Vimeo, the home for high quality videos and the people who love them.
bitly.cx